Cargando…
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
PURPOSE: Frequently the infection with coronavirus 2 (SARS-CoV-2) can be asymptomatic or provoke only mild symptoms. These cases often remain unnoticed, so it is difficult to estimate the actual numbers of infections. Aim of this study was to determine the seroprevalence of anti-SARS-CoV-2 total ant...
Autores principales: | Weidner, Lisa, Nunhofer, Verena, Jungbauer, Christof, Hoeggerl, Alexandra Domnica, Grüner, Lydia, Grabmer, Christoph, Zimmermann, Georg, Rohde, Eva, Laner-Plamberger, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208066/ https://www.ncbi.nlm.nih.gov/pubmed/34132990 http://dx.doi.org/10.1007/s15010-021-01639-0 |
Ejemplares similares
-
Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection
por: Nunhofer, Verena, et al.
Publicado: (2022) -
Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course
por: Hoeggerl, Alexandra Domnica, et al.
Publicado: (2023) -
SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability
por: Laner-Plamberger, Sandra, et al.
Publicado: (2022) -
Sample Buffer Containing Guanidine-Hydrochloride Combines Biological Safety and RNA Preservation for SARS-CoV-2 Molecular Diagnostics
por: Weidner, Lisa, et al.
Publicado: (2022) -
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
por: Gimona, Mario, et al.
Publicado: (2017)